|
Intismeran autogene Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: V940, mRNA-4157
Anchorage, Alaska1 trial
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Alaska Oncology and Hematology ( Site 0039)
Phase 3
Gilbert, Arizona1 trial
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Banner MD Anderson Cancer Center ( Site 0181)
Phase 3
Bakersfield, California1 trial
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Michael G Oefelein Clinical Trials ( Site 0138)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.